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ABSTRACT
Frog is a web tool dedicated to small compound 3D
generation. Here we present the new version, Frog2,
which allows the generation of conformation en-
sembles of small molecules starting from either
1D, 2D or 3D description of the compounds. From
a compound description in one of the SMILES, SDF
or mol2 formats, the server will return an ensemble
of diverse conformers generated using a two stage
Monte Carlo approach in the dihedral space. When
starting from 1D or 2D description of compounds,
Frog2 is capable to detect the sites of ambiguous
stereoisomery, and thus to sample different stereo-
isomers. Frog2 also embeds new energy minimiza-
tion and ring generation facilities that solve the
problem of some missing cycle structures in the
Frog1 ring library. Finally, the optimized generator
of conformation ensembles in Frog2 results in a
gain of computational time permitting Frog2 to be
up to 20 times faster that Frog1, while producing
satisfactory conformations in terms of structural
quality and conformational diversity. The high
speed and the good quality of generated conform-
ational ensembles makes it possible the treatment
of larger compound collections using Frog2. The
server and documentation are freely available at
http://bioserv.rpbs.univ-paris-diderot.fr/Frog2.
INTRODUCTION
Disposing the 3D structure of small drug-like molecules
can be critical for several computational approaches such
as in silico screening (1,2), either ligand-based (3–5) or
receptor structure-based (6–9) employed prior to or to
complement experimental screening for hit identiﬁcation,
lead optimization or chemical biology purposes. In
addition, for some of the methods, like rigid ligand
docking or 3D ligand-based screening, a multiple con-
former ensemble is required. Chemical compounds are
often distributed by chemical vendors in 1D SMILES
(simpliﬁed molecular input line entry system), 1D
cansmiles (canonical SMILES) (10) or in 2D SDF (11)
(structure data ﬁle) formats. Generating an accurate 3D
structure for a small chemical compound is a complex task
(12). Diﬀerent techniques using rule-based or data-based
methods, building linker regions on pre-generated frag-
ments or stochastic procedures up to quantum mechanical
methods (12,13) have been developed. Numerous studies
have been carried out to compare the existing approaches
and to analyze the small molecule conformations experi-
mentally observed (14,15). They revealed that for a satis-
factory sampling of the conformational space, the most
important parameters to be optimized are the energy
window with respect to the global minimum and the
root mean square deviation (RSMD) value. Several well
established commercial packages such as Corina (Corina
Molecular Networks, GmbH Computerchemie
Langemarckplatz 1, Erlangen, Germany, 2000), Omega,
Catalyst (14) or MED-3DMC (16) generate multiple
ensemble conformations of small molecules. In addition,
several utilities like Zinc (17), FAF-drugs (18) or
pubChem (18) take advantage of commercial software to
propose pregenerated collections of compounds in 3D.
Yet, very few free tools are available for a single or mul-
tiple conformation generation. For instance, Balloon (13)
using a multi-objective genetic algorithm approach
and Multiconf-DOCK http://dock.compbio.ucsf.edu/
Contributed_Code/index.htm (20) using a systematic
search are freely available. The open source program
DG-AMMOS (21) based on a distance geometry
approach and molecular mechanics optimization has
been recently reported. A practical alternative of the
standalone packages, in particular for non-advanced
users, are the web services which can provide direct
1D/2D to 3D facilities, such as OpenEye’s Omega,
Molsoft, Corina and from some academic sites such as
at CBS. Such services, however, usually treat one
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reported the web-service Frog (22) (http://bioserv.rpbs
.univ-paris-diderot.fr/Frog.html) providing an on-line
generation of a single or ensembles of 3D conformations
for drug-like compounds. Frog is a mixed rule-based data-
based approach based on Frowns (a chemoinformatics
toolkit available at http://frowns.sourceforge.net/) to
which several functionalities have been added to allow
the generation of 3D structures starting from SMILES
or SDF data input.
Here, we describe a new version of Frog, Frog2, which
is able to (i) generate single or ensembles of low to medium
energy 3D conformations starting from 1D/2D or 3D
input structure, to (ii) fully or partially disambiguate
compound stereochemistry including chiral sites with a
user-deﬁned maximum number of generated conformers,
and to (iii) minimize the energy of the generated conform-
ers using AMMOS (18) if the user requires. The following
important improvements are achieved in Frog2 compared
to Frog1: (i) generation of compound rings not available
in the fragment database of Frog1 using DG-AMMOS
(17); (ii) signiﬁcantly improved diversity of the generated
conformer ensembles, and (iii) considerable increase of the
computation speed. In addition, several ancillary tools are
provided, such as the format interconversion using
OpenBabel (23) or energy minimization of 3D conform-
ations via AMMOS (24). Frog2 still does not allow ring
ﬂexibility during the multiple conﬁrmation generation
which is under development.
In this study, in addition to describing the web-service
Frog2, we validate Frog2 on compounds from the Astex
dataset (25). The comparison of Frog2 with Frog1 and the
commercial package Omega (http://www.eyesopen.com)
shows persuasive performance of Frog2.
METHODS
Concepts
A general overview of the Frog2 service is presented in
Figure 1. The new and the optimized modules of Frog2
are shown in the gray white boxes. Overall, the Frog
internal 3D generation is based on a graph decomposition
of the compound (22) coupled with an identiﬁcation of the
stereo centers for which the chirality is unspeciﬁed. Once
these sites have been identiﬁed, the combinatorial of the
unambiguous isomers—for which the chirality of all the
identiﬁed stereo centers is completely speciﬁed—is
generated, but randomly truncated to a maximum of
eight chiral centers for 3D generation. For each of these,
a starting 3D conformation is generated. During this gen-
eration, Frog2 takes advantage of DG-AMMOS to
generate on the ﬂy missing rings and adds them to the
ring library, thus escaping a major limitation of Frog1.
Frog does not manage the protonation explicitly.
Instead, it relies on OpenBabel (23) to generate
hydrogen coordinates for a standard protonation state.
Another Frog2 major improvement comes from the op-
timization of the conformation ensemble generation
engine. As in Frog1 however, rings are maintained rigid
and only dihedral variations are considered. Frog2 engine
embeds an improved two stage Monte Carlo procedure.
The ﬁrst stage explores the conformational ﬂexibility
based on a limited number of representative dihedral
angular values depending on atom types. This Monte-
Carlo step includes a procedure to avoid conformation
redundancy: new conformations that correspond to previ-
ously visited combinations of dihedral values are
forbidden. Also, the possibility of biasing the exploration
of dihedral values depending on their position relative to
the center of the compound has been introduced. For this,
the probability that a step aﬀects a particular dihedral is
not uniform, but depends on the number of ﬂanking
atoms at each side, using the following weight: nl  nr=nt,
where nl (resp. nr) is the number of atoms at the left (resp.
right) of the bond undergoing the rotation, nt is the total
number of atoms, so that dihedrals located at terminal
positions have smaller weights compared to dihedrals
having a balanced number of atoms each side. The
second-stage Monte Carlo uniformly considers small ro-
tations within the stage one conformations, so as to reﬁne
them. In order to prune the combinatorial exploration,
this stage two is active by default only for conformations
of high enough energies.
This described conformation ensemble generation
engine is supplemented by a standard divisive hierarchical
clustering using an approach similar in essence to that
used for ﬁngerprints (26). This approach guarantees that
all conformers in a class are below a ﬁxed RMSD thresh-
old and that the RMSD between selected conformers are
always above that threshold.
Finally, in order to speed the computations, the rank of
the conformers is based on an internal score of Frog2
taking into account only van der Waals interactions,
which might be insuﬃcient to prevent some geometry
Figure 1. Flowchart of Frog2.
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limitation, it is possible to minimize the conformers using
the AMMP force ﬁeld as implemented in AMMOS (24).
Input/output
Frog2 accepts as input three formats widely used by the
community: SMILES, SDF and mol2 formats. It is
possible to convert to one of these ones using the
OpenBabel facility. Since the SDF and mol2 formats can
correspond to both 2D or 3D descriptions of a compound,
the user must be precise among the two possible types of
input: 1D/2D or 3D. Specifying the 1D/2D type, all 3D
information of the input will be discarded and the 3D
generation will be performed from scratch. Specifying
the 3D type, Frog2 will simply call the conformation
ensemble generation engine, not considering stereo-
isomery and taking the input coordinates as a starting
point for the conformation ensemble generation.
Parameters related to the generation of ensembles corres-
pond to a maximal number of conformations, and energy
thresholds to deﬁne the allowed energy window referred to
the lowest energy conformation generated. It is also
possible to specify a minimal RMSD value for geometric
clustering of the conformers, and to invoke the minimiza-
tion of the compounds. The minimization is only applied
on exit of the generation. The energy minimization takes
into account the valence, angle and van der Waals com-
ponents, not considering electrostatics terms. The internal
format for the Frog2 results is mol2. It is, however,
possible to choose between mol2, SDF or PDB formats,
thanks to OpenBabel.
RESULTS
We ﬁrst assessed the Frog2 performance for ﬁnding con-
formation similar to bioactive ones among the generated
multiconformation ensemble. Figure 2 shows the results
for generating multiconformation ensembles of the Astex
dataset (25) containing 85 diverse drug-like molecules
using Frog2, Frog1 and Omega 2 [Openeye Scientiﬁc
Software (http://www.eyesopen.com)]. The same input
parameters were applied to run Frog2, Frog1 and
Omega, namely: up to 50 conformers, RMSD threshold
of 0.8.A ˚ . In order to make possible the comparison with
Frog1, the Frog2 disambiguation option was activated. As
can be seen from Figure 2a, using these input parameters,
applying unambiguation for the stereoisomery and
allowing the stage two Monte-Carlo, Frog2 ﬁnds con-
formations closer to the bioactive ones than Frog1 for
most of the Astex molecules. On average, the Frog2 bio-
active’ closest conformation is at 0:78  0:40A ˚ RMSD
values whereas Frog1 shows an average RMSD of
0:93  0:48A ˚ . Interestingly, Frog2 performs better than
Frog1 even without employing the stage two Monte
Carlo with an average RMSD of 0:83  0:48, respectively.
Similar results in terms of RMSD are obtained using
Frog2 and Omega when a maximum of 50 conformers
were generated on the Astex dataset with a slight, outper-
formance of Omega with average values being of
0:69  0:37 (Wilcoxon signed rank test shows no signiﬁ-
cant diﬀerence). For a maximum of 50 conformers per
molecule, Omega and Frog2 found conformations within
an RMSD with the bioactive one of 1.5A ˚ for 82 and 79
compounds out of 85, respectively. That can be considered
as an acceptable accuracy keeping in mind that the
required RMSD for clustering the similar conformations
was set to 0.8A ˚ . Finally, Figure 2c illustrates the impact of
increasing the maximal number of conformers up to 100.
One notes a small, but eﬀective improvement. On average,
Frog2 ﬁnds the bioactive conformation within
0:73  0:42A ˚ RMSD. Examples demonstrating the con-
formational diversity achieved by Frog2 and Omega
when 50 conformers generated for two molecules of the
Astex dataset can be seen in Figure 3. According to the
computed RMSD values and visual analysis, one can
conclude that both Frog2 and Omega explore quite well
the conformational space and are able to generate con-
formations that are close to the bioactive one. In
addition, the user has the possibility to energy-minimize
the generated conformers via Frog2 or to minimize a own
compound library in 3D. Our assessment of the impact of
the minimization on the Frog2-generated Astex conform-
ers does not show a signiﬁcant improvement by means of
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Figure 2. RMSD between the best-ﬁtted conformers and the X-ray structures for conformers generated by: (a) Frog1 versus Frog2 for series of up to
50 conformers; (b) Frog2 versus Omega for series of up to 50 conformers. PDB codes denote (i) the compounds with poorest relative performance,
i.e. deviating the most from the diagonal (1y6b, 1xoz) and (ii) best performing for both Frog2 and Omega (1gpk, 1u4d, 1sqn); and (c) Frog2 for
series of up to 50 conformers versus Frog2 for series of up to 100 conformers.
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RMSD from the bioactive conformations was of
0:74  0:44A ˚ , i.e. similar results to the ones obtained by
Frog2 without a ﬁnal minimization stage. In addition, we
validated the Frog2 performance on a larger collection of
compounds taken from the PDBbind database (27). We
extracted all PDBbind ligands with an X-ray resolution
better than 2A ˚ . The compounds contatining up to 15 ro-
tatable bonds and not including large bridged rings (more
than 30 atoms, see the discussion about Frog2 limitations
above) were retained. Finally, 962 compounds were
treated. The distribution of the resulted test-set com-
pounds depending on the number of rotatable bonds is
given in the Supplementary Data. The results for RMSD
between the best generated and experimental structures
are also given in the Supplementary Data. The conformer
ensembles were generated for a maximum of 50 conform-
ers, enabling stage two Monte Carlo, and without
applying minimization. As can be expected, the perform-
ance (in terms of RMSD) decreases with increasing
molecular ﬂexibility. The median RMSD to the experi-
mental conformation is below 1A ˚ up to 7 rotatable
bonds, and Frog2 results remain however acceptable up
to 15 rotatable bonds.
Finally, we assessed the gain in speed of Frog2
compared to Frog1. On a computer with intel Xeon pro-
cessors at 2GHZ, Omega-generated conformers for all the
Astex set in 6min. The generation using Frog2 required
11min. Using comparable parameters, Frog1 generated
the same collection in 103min. In addition, the computa-
tional time can be reduced to 5min if Frog2 is run without
the two Monte Carlo stage. In summary, Frog2 generates
better conformational quality and diversity than Frog1
and is nine times faster than Frog1 using conditions
strictly comparable. Frog2 still outperforms Frog1 when
employing the faster approach without two-stage Monte
Carlo in terms of conformational diversity and is 20 times
faster. This dramatic decrease in execution time without
aﬀecting the quality of the generated conformations
demonstrates the impact of the optimizations
implemented into Frog2. We should note that activating
the minimization option leads to signiﬁcant increase of the
computational time. Over the Astex set, using the disam-
biguation option and stage two Monte Carlo, the calcula-
tion times increased from 11min up to 207min, i.e. close
to 20 times slower. However, the minimization may be
required to energy-minimize some generated structures
with detected structural inaccuracies, or for a small
number of compounds.
DISCUSSION AND FUTURE DIRECTIONS
The main goal of the Frog2 development was to overcome
several limitations of Frog1 and to increase the overall
quality and speed performance. Over these, rings were a
central concern. Indeed, Frog2 dependency on a ring
library is much less critical since Frog2 takes the advan-
tage of DG-AMMOS to generate on the ﬂy missing rings.
Furthermore, Frog2 addresses a Frog1 issue problem
related to rings’ protonation now generated standardly
via OpenBabel. As a result, the Frog2 failure rate to
generate conformers is low. Used over 10000 compounds
randomly selected out of 400000cmps from the
ChemBrdge diverset (http://www.chembridge.com/),
Frog2 only failed to generate conformers for <2% of
the compounds. As illustrated from the tests on the
Astex set, Frog2 reaches a good structure quality.
A second focus concerned the conformational diversity.
The Frog2 development permitted to better control the
diversity in the conformation ensemble generation and
Frog2 reaches extensive conformational diversity.
Further improvements are expected. In particular, better
consideration of symmetry is under investigation.
Last focus was related to needed computational time.
Indeed, in a context of virtual screening experiments,
where millions of compounds can be considered, the
time to generate libraries can become a concern. One
can suppose that once generated in 3D, a chemical
compound collection can be in silico screened for diﬀerent
projects, however, more and more generation of focused
Figure 3. Conformational ensembles for two small molecules of the Astex dataset generated by Frog2 (all atom colors, carbons in yellow) and
Omega (all atom colors, carbons in light pink: (a) PDB code 1jla; and (b) PDB code 1meh. The experimental structure of the co-crystallized ligands
are also shown (all atom colors, carbons in magenta).
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increase the eﬃciency of discovery programs. In this
respect, Frog2 brings signiﬁcant improvement since it is
able to generate satisfactory quality conformations 20
times faster than Frog1. We should note that a balance
between the speed and conformational diversity can be
achieved depending on the project purposes and the
number of compounds to treat. Inactivating the stage
two Monte Carlo, operational on the server, will result
in a faster generation, but a reduced conformational di-
versity will be reached. For applications requiring best
explored conformational space, it is thus recommended
to maintain this stage active. Finally, Frog2 takes advan-
tage of AMMOS to oﬀer the possibility to minimize the
conformations that can be very helpful in some particular
cases, even its use results in dramatically larger computa-
tional cost.
Several limitations are still present in Frog2. The ﬁrst
one is related to the ring rigidity that can aﬀect the quality
or the diversity of the conformations generated in some
cases. Particularly, compounds including large bridged
rings for which ﬂexibility impacts the conformational
search are presently out of Frog scope. Also, a side
eﬀect of the ring library strategy is that Frog2 is presently
not able to treat properly some cases of stereoisomery
involving stereo centers in rings. Finally, some errors in
the generation of some particular groups can be presently
observed since Frog2 builds from scratch the linkers, at a
single atom level, i.e. not combining pregenerated frag-
ments. Eﬀorts will now focus on the implementation of
speciﬁc rules for such groups. In addition, the implemen-
tation of some ring ﬂexibility is under development.
Despite of the minor current limitations, the assessment
of Frog2 demonstrated a convincing performance. The use
of Frog2 could help for various in silico studies, from
ligand-based or structure-based virtual screening, to lead
compounds optimization etc. Thus, the Frog2 server oﬀers
a very valuable tool which provides eﬃcient features to the
community for an extremely competitive computational
time.
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Supplementary Data are available at NAR Online.
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